Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 26% ± 10% |
Insufficient scRNA-seq data for expression of HTR2C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 69% | 1442.95 | 1819 / 2642 | 35% | 1.96 | 244 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.05 | 1 / 1 |
esophagus | 0% | 0.18 | 1 / 1445 | 31% | 1.02 | 56 / 183 |
bladder | 0% | 0 | 0 / 21 | 31% | 0.96 | 154 / 504 |
lung | 0% | 0.22 | 1 / 578 | 26% | 0.94 | 302 / 1155 |
ovary | 0% | 0 | 0 / 180 | 16% | 0.39 | 67 / 430 |
skin | 0% | 0.42 | 4 / 1809 | 15% | 0.58 | 71 / 472 |
uterus | 1% | 1.27 | 2 / 170 | 10% | 0.30 | 45 / 459 |
stomach | 0% | 0 | 0 / 359 | 7% | 0.17 | 19 / 286 |
intestine | 0% | 0 | 0 / 966 | 7% | 0.16 | 35 / 527 |
thymus | 0% | 0 | 0 / 653 | 4% | 0.15 | 24 / 605 |
pancreas | 0% | 0 | 0 / 328 | 4% | 0.12 | 7 / 178 |
breast | 0% | 0 | 0 / 459 | 3% | 0.10 | 36 / 1118 |
prostate | 2% | 4.49 | 5 / 245 | 1% | 0.04 | 3 / 502 |
liver | 0% | 0 | 0 / 226 | 2% | 0.07 | 10 / 406 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.07 | 3 / 230 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 7 / 901 |
muscle | 0% | 0.10 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.19 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0019934 | Biological process | cGMP-mediated signaling |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0007631 | Biological process | feeding behavior |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0007210 | Biological process | serotonin receptor signaling pathway |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0098664 | Biological process | G protein-coupled serotonin receptor signaling pathway |
GO_0032098 | Biological process | regulation of appetite |
GO_0010513 | Biological process | positive regulation of phosphatidylinositol biosynthetic process |
GO_0007208 | Biological process | phospholipase C-activating serotonin receptor signaling pathway |
GO_0043397 | Biological process | regulation of corticotropin-releasing hormone secretion |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0031644 | Biological process | regulation of nervous system process |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0001662 | Biological process | behavioral fear response |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0007626 | Biological process | locomotory behavior |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0098666 | Cellular component | G protein-coupled serotonin receptor complex |
GO_0042802 | Molecular function | identical protein binding |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0051378 | Molecular function | serotonin binding |
GO_0071886 | Molecular function | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0001587 | Molecular function | Gq/11-coupled serotonin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HTR2C |
Protein name | 5-hydroxytryptamine (Serotonin) receptor 2C 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C) 5-hydroxytryptamine receptor 2C variant b |
Synonyms | HTR1C |
Description | FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling activates a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and down-stream signaling cascades and promotes the release of Ca(2+) ions from intracellular stores. Regulates neuronal activity via the activation of short transient receptor potential calcium channels in the brain, and thereby modulates the activation of pro-opiomelacortin neurons and the release of CRH that then regulates the release of corticosterone. Plays a role in the regulation of appetite and eating behavior, responses to anxiogenic stimuli and stress. Plays a role in insulin sensitivity and glucose homeostasis. . |
Accessions | Q7Z579 ENST00000371950.3 [P28335-2] B3VRF5 B3VRF0 P28335 ENST00000371951.5 [P28335-1] ENST00000276198.6 [P28335-1] B3VRE0 B3VRE5 |